Search results
Showing 101 to 150 of 635 results for diabetes
Number of people with diabetes with a single marker of all 9 basic care processes performed
of people with diabetes with a single marker of all 9 basic care processes performed Subject(s): Diabetes
The percentage of patients with diabetes aged 40 years and over, with no history of cardiovascular disease and without moderate or...
newly diagnosed diabetes who are offered structured education within 3 months of diagnosis Subject(s): Diabetes
adults with diabetes referred to a structured education programme within 12 months of diagnosis Subject(s): Diabetes
with diabetes, on the register, who have had influenza immunisation in the preceding 1 August to 31 March Subject(s):...
The percentage of patients with diabetes with a record of testing of foot sensation using a 10g monofilament within the preceding 12...
The percentage of patients with diabetes and a history of cardiovascular disease (excluding a history of haemorrhagic stroke) who are...
Acute kidney injury: prevention, detection and management (NG148)
This guideline covers preventing, detecting and managing acute kidney injury in children, young people and adults. It aims to improve assessment and detection by non-specialists, and specifies when people should be referred to specialist services. This will improve early recognition and treatment, and reduce the risk of complications in people with acute kidney injury.
The percentage of patients with diabetes, on the register, in whom the last IFCC-HbA1c is 58 mmol/mol or less in the preceding 12 months
Unplanned hospitalisation for asthma, diabetes and epilepsy in under 19s
Unplanned hospitalisation for asthma, diabetes and epilepsy in under 19s Subject(s): Outpatient and community care
young people with diabetes who have received a psychological assessment in the previous 12 months Subject(s): Diabetes
patients with diabetes, on the register, who have a record of retinal screening in the preceding 12 months Subject(s):...
eligible people with diabetes who have not attended for diabetic eye screening in the previous 3 years Subject(s): Diabetes
This quality standard covers recognising, assessing and managing coeliac disease in adults, young people and children. It describes high-quality care in priority areas for improvement.
View quality statements for QS134Show all sections
Sections for QS134
- Quality statements
- Quality statement 1: Serological testing for coeliac disease
- Quality statement 2: Referral to a specialist
- Quality statement 3: Endoscopic intestinal biopsy
- Quality statement 4: Advice about a gluten-free diet
- Quality statement 5: Annual review
- Update information
- About this quality standard
people with diabetes who are suspended from diabetic eye screening due to previous screening results Subject(s): Diabetes
This guideline covers assessing and treating bedwetting in people aged under 19. It aims to reduce bedwetting and the distress this causes by explaining what to ask in an assessment, what advice to provide, and which treatments are effective.
NICE indicators. NM70 diabetes guidance.
NICE's impact on managing long-term conditions in children in the community
with a diagnosis of diabetes who have a recording of MI, stroke and/or end stage kidney disease Subject(s): Diabetes
type 1 diabetes and other types of diabetes: What are the best clinical features or combination of features for...
people with diabetes who have had their glycated haemoglobin A1c (HbA1c) monitored in the previous 12 months Subject(s):...
people with type 1 diabetes who have been screened for thyroid disease in the previous 12 months Subject(s): Diabetes
aged 12-18 years with diabetes who have a record of eye screening in the previous 12 months Subject(s): Diabetes Date
This guideline covers managing stable angina in people aged 18 and over. It outlines the importance of addressing the person’s concerns about stable angina and the roles of medical therapy and revascularisation.
Evidence-based recommendations on liraglutide (Saxenda) for managing overweight and obesity alongside a reduced-calorie diet and increased physical activity in adults.
The percentage of patients with diabetes, on the register, in whom the last IFCC-HbA1c is 64 mmol/mol or less in the preceding 12 months
The percentage of patients with diabetes, on the register, in whom the last IFCC-HbA1c is 75 mmol/mol or less in the preceding 12 months
people with diabetes age 12 -18 years who have had their smoking status recorded in the previous 12 months Subject(s):...
12-18 years with diabetes who have had their blood pressure recorded in the previous 12 months Subject(s): Diabetes
12-18 years with diabetes who have had their urinary albumin recorded in the previous 12 months Subject(s): Diabetes
This quality standard covers recognising, assessing and managing bipolar disorder in adults (aged 18 and over) in primary and secondary care. It describes high-quality care in priority areas for improvement.
View quality statements for QS95Show all sections
Sections for QS95
- Quality statements
- Quality statement 1: Referral for specialist mental health assessment
- Quality statement 2: Personalised care plan
- Quality statement 3: Involving carers in care planning
- Quality statement 4 (developmental): Psychological interventions
- Quality statement 5: Maintaining plasma lithium levels
- Quality statement 6: Valproate
- Quality statement 7: Assessing physical health
under 18 years old with diabetes, who have their BMI recorded in the previous 12 months Subject(s): Diabetes Date of
The proportion of eligible people with diabetes who are excluded from diabetic eye screening as they have opted out or are classed as...
Evidence-based recommendations on using coronary artery stents in adults.
inhibitor if they have either: no type 2 diabetes and a urine ACR of 22.6 mg/mmol or more, or type 2 diabetes and a urine...
Summary of the evidence on avanafil for treating erectile dysfunction to inform local NHS planning and decision-making
12-18 years with diabetes who have a record of a foot examination in the previous 12 months Subject(s): Diabetes
between 25 and 84 years with a new diagnosis of hypertension or type 2 diabetes, recorded in the preceding 12 months (excluding those...
The percentage of patients with diabetes, on the register, with a diagnosis of nephropathy (clinical proteinuria) or micro-albuminuria...
Evidence-based recommendations on empagliflozin (Jardiance) for treating chronic kidney disease in adults.
between 25 and 84 years, with a new diagnosis of hypertension or type 2 diabetes recorded in the preceding 12 months (excluding those...
This quality standard covers the assessment and management of chronic kidney disease in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.
Remdesivir and tixagevimab plus cilgavimab for treating COVID-19 [ID6261]
In development [GID-TA11297] Expected publication date: 08 May 2024
use of C-peptide in diagnosing diabetes: What is the effectiveness of C‑peptide at correcting misclassification of diabetes...
The percentage of patients with diabetes who have had the following care processes performed in the preceding 12 months: BMI...
This quality standard covers preventing, detecting and managing acute kidney injury in adults, young people and children. It describes high-quality care in priority areas for improvement.
View quality statements for QS76Show all sections
Sections for QS76
- Quality statements
- Quality statement 1: Raising awareness in people at risk
- Quality statement 2: Identifying acute kidney injury in people admitted to hospital
- Quality statement 3: Response to acute kidney injury warning stage 2 test result
- Quality statement 4: Response to acute kidney injury warning stage 3 test result
- Quality statement 5: Referral for renal replacement therapy
- Quality statement 6: Clinical review after hospital discharge
- Update information
The percentage of patients with diabetes with moderate or severe frailty, on the register, in whom the last IFCC-HbA1c is 75 mmol/mol or...
The percentage of patients with diabetes without moderate or severe frailty, on the register, in whom the last IFCC-HbA1c is 58 mmol/mol...
Monitoring for cystic-fibrosis-related diabetes:- What is the most effective strategy to detect diabetes in people with...
Cellulitis and erysipelas: antimicrobial prescribing (NG141)
This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with cellulitis and erysipelas. It aims to optimise antibiotic use and reduce antibiotic resistance.